<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1018</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>UDKhK - novye vozmozhnosti v usloviyakh pandemii</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Article</surname><given-names>Editorial</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1"></aff><pub-date date-type="epub" iso-8601-date="2020-12-11" publication-format="electronic"><day>11</day><month>12</month><year>2020</year></pub-date><issue>11-12</issue><fpage>25</fpage><lpage>25</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><kwd-group xml:lang="ru"><kwd>УДХК</kwd><kwd>урсодезоксихолевая кислота</kwd><kwd>воспаление дыхательных путей</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Available at: https://my.cnki.net/documentdetail. html?fileName=1020619543.nh&amp;productld=CDFD&amp;fr om=RecentlyBrowse.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Willart M.A.M., van Nimwegen M., Grefhorst A., Hammad H., Moons L., Hoogsteden H.C., Lambrecht B.N. et al. Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor. Allergy. 2012;67(12):1501-1510. doi: 10.1111/all.12019.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Işık S., Karaman M., Çilaker Micili S., Çağlayan- Sözmen Ş., Bağrıyanık H.A., Arıkan-Ayyıldız Z. et al. Beneficial effects of ursodeoxycholic acid via inhibition of airway remodelling, apoptosis of airway epithelial cells, and Th2 immune response in murine model of chronic asthma. Allergol Immunopathol (Madr). 2017;45(4):339-349. doi: 10.1016/j. aller.2016.12.003.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Niu F., Xu X., Zhang R., Sun L., Gan N., Wang A. Ursodeoxycholic acid stimulates alveolar fluid clearance in LPS-induced pulmonary edema via ALX/cAMP/PI3K pathway. J Cell Physiol. 2019;1-9. doi: 10.1002/jcp.28602.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Winston J.A., Rivera A.J., Cai J., Thanissery R., Montgomery S.A., Patterson A.D., Theriot C.M. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids. Infect Immun. 2020;88(6):e00045-20. doi: 10.1128/ IAI.00045-20.</mixed-citation></ref></ref-list></back></article>
